Searchable abstracts of presentations at key conferences in endocrinology

ea0035p403 | Diabetes complications | ECE2014

Does proton pump inhibitor use decrease microvascular complicaton rate in type 2 diabetic patients? A retrospective analysis

Kut Altug , Bozkus Yusuf , Anil Cuneyd , Tutuncu Neslihan Bascil

Proton pump inhibitor (PPI) drugs which are used safely to treat peptic ulcus disease since 2 decades, moderately increases gastrin hormone by decreasing gastric acid secretion. Preclinical studies show that gastrin itself, or drugs that increase gastrin levels such as PPIs, increase islet cell mass and improve glycaemic control. To the best of our knowledge one prospective and some retrospective studies claim that PPI medication in diabetic patients leads to an average decrea...

ea0035p469 | Diabetes therapy | ECE2014

Effect of angiotensin receptor blockers on glycaemic control in type 2 diabetic patients? A retrospective analysis

Bozkus Yusuf , Kut Altug , Kirnap Nazli , Tutuncu Neslihan Bascil

Experimental and clinical studies suggest that blocking the effects of angiotensin II increases insulin sensitivity, skeletal muscle glucose transport, and pancreatic blood flow which may contribute to the prevention of diabetes mellitus. Although large scale studies and meta-analysis reveal that the new onset of diabetes could be significantly decreased by ARBs in both hypertensive and normotensive patients, their effect on glucose regulation in patients already diagnosed wit...

ea0035p470 | Diabetes therapy | ECE2014

Comparison of angiotensin receptor blockers and angiotensin converting enzyme inhibitors for glycaemic regulation

Kut Altug , Bozkus Yusuf , Firat Sevde Nur , Tutuncu Neslihan Bascil

Large scale clinical studies and meta-analysis suggest that treatment with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) could have protective effect against diabetes development. While diuretics and β-blockers have some well known adverse effect on glycaemic regulation, ARBs/ACEIs’ effect on glucose regulation in patients already diagnosed with diabetes has not been investigated well enough. Also to the best of our knowled...

ea0049ep39 | Adrenal cortex (to include Cushing's) | ECE2017

The clinical course of patients with adrenal incidentaloma: Başkent University experience

Kirnap Nazli Gulsoy , Iyidir Ozlem Turhan , Bozkus Yusuf , Ramazanova Lala , Nar Asli , Kut Altug , Tutuncu Neslihan

The prevalance of incidentally discovered adrenal masses increased in last three decades. The major clinical concern is the risk of malignancy and hormone overproduction but most of them are non-fonctional and benign. Current practices in the management of adrenal incidentalomas reevaluated the follow-up suggestions considering low probability of the transformation of a benign and non-functional adrenal mass to a malignant or functional one. Therefore, in the present study we ...

ea0035p468 | Diabetes therapy | ECE2014

Does statin use impairs glycaemic control in type 2 diabetic patients? A retrospective analysis

Bozkus Yusuf , Kut Altug , Anil Cuneyd , Isildak S Mehlika , Tutuncu Neslihan Bascil

While statins which are used safely to treat dyslipidemia, and improve cardiovascular mortality, recent articles claim that they also impairs glycaemic control in type 2 diabetes patients. Meta-analysis of larger scale studies indicate that use of statins is associated with an increase of 9% in diabetes onset. Despite that, we know not much about their effect on glucose regulation in patients already diagnosed with diabetes. Therefore, we aimed to investigate the effect of sta...

ea0032p995 | Thyroid (non-cancer) | ECE2013

Metformin decreases thyroid volume and nodule size in subjects with insulin resistance

Gursoy Alptekin , Anil Cuneyd , Atesagaoglu Berna , Kut Altug , Nar Asli , Bascil Tutuncu Neslihan

Introduction: Previous reports have shown that subjects with insulin resistance have increased thyroid volume and nodule prevalence. We investigated the effects of metformin on thyroid volume and nodule size.Methods: This prospective data were gathered on newly diagnosed subjects with insulin resistance (n=100, 68 female, 32 male) between August 2008 and May 2010. Measurements of thyroid hormones and thyroid ultrasonography was performed in all ...

ea0022p852 | Thyroid | ECE2010

Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area

Ayturk Semra , Gursoy Alptekin , Kut Altug , Anil Cuneyd , Nar Asli , Tutuncu Neslihan Bascil

Objective: The metabolic syndrome (MetS) is a cluster of metabolic abnormalities with insulin resistance (IR) as a major characteristic. It has been recently questioned that MetS and its related components are associated with functional and morphological alterations of thyroid gland. Aim of our study is to examine thyroid volume and nodule prevalence in patients with MetS in a mild-to-moderate iodine deficient area.Design: Two hundred and seventy-eight p...